Building an innovative Chagas disease program for primary care units, in an urban non- endemic city by Ana Cristina Pereiro, Silvia Gold

Connect to this object online.

Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Se... by Jaime Algorta, Alejandro Krolewiecki, Alejandro Krolewiecki, Filipe Pinto, Silvia Gold, Jose Muñoz

Connect to this object online.

Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers. by Jose Muñoz, Maria Rosa Ballester, Rosa Maria Antonijoan, Ignasi Gich, Montse Rodríguez, Enrico Colli, Silvia Gold, Alejandro J Krolewiecki

Connect to this object online.

Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A comm... by Adriana Echazú, Marisa Juarez, Paola A Vargas, Silvana P Cajal, Ruben O Cimino, Viviana Heredia, Silvia Caropresi, Gladys Paredes, Luis M Arias, Marcelo Abril, Silvia Gold, Patrick Lammie, Alejandro J Krolewiecki

Connect to this object online.

The BENEFIT Trial: Where Do We Go from Here? by Bernard Pecoul, Carolina Batista, Eric Stobbaerts, Isabella Ribeiro, Rafael Vilasanjuan, Joaquim Gascon, Maria Jesus Pinazo, Silvia Moriana, Silvia Gold, Ana Pereiro, Miriam Navarro, Faustino Torrico, Maria Elena Bottazzi, Peter J Hotez

Connect to this object online.